Studies show that approximately one-third of weight loss from these drugs comes from muscle and bone, not just fat
Dulaglutide: a novel once-weekly glucagon-like peptide-1 receptor agonist
A programme of phase 3 trials with retatrutide (TRIUMPH) is ongoing with an aim to assess the safety and efficacy of retatrutide in different populations living with obesity (OSA, T2D, established cardiovascular disease, osteoarthritis)
How long does it take for Ozempic to show weight loss results compared to insulin
Discover the March featured product, Liver/Kidney Supplements, which targets the bodys filtration functions
When it comes to shedding body fat and overall losing weight, not everyone has the best of luck with diet and standard fat burners